Meeting Report of the 2nd Lugano ExoDay: Extracellular Vesicles As Next-generation Clinical Biomarkers and Therapeutic Agents
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Gori A, Romanato A, Greta B, Strada A, Gagni P, Frigerio R
. Membrane-binding peptides for extracellular vesicles on-chip analysis. J Extracell Vesicles. 2020; 9(1):1751428.
PMC: 7178839.
DOI: 10.1080/20013078.2020.1751428.
View
2.
Luque A, Farwati A, Krupinski J, Aran J
. Association between low levels of serum miR-638 and atherosclerotic plaque vulnerability in patients with high-grade carotid stenosis. J Neurosurg. 2018; 131(1):72-79.
DOI: 10.3171/2018.2.JNS171899.
View
3.
Kovacs A, Lang O, Turiak L, Acs A, Kohidai L, Fekete N
. The impact of circulating preeclampsia-associated extracellular vesicles on the migratory activity and phenotype of THP-1 monocytic cells. Sci Rep. 2018; 8(1):5426.
PMC: 5882809.
DOI: 10.1038/s41598-018-23706-7.
View
4.
Keklikoglou I, Cianciaruso C, Guc E, Squadrito M, Spring L, Tazzyman S
. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell Biol. 2019; 21(2):190-202.
PMC: 6525097.
DOI: 10.1038/s41556-018-0256-3.
View
5.
Grange C, Bussolati B
. Extracellular vesicles in kidney disease. Nat Rev Nephrol. 2022; 18(8):499-513.
PMC: 9152665.
DOI: 10.1038/s41581-022-00586-9.
View